J
Jeanine Kamphuis
Researcher at Mental Health Services
Publications - 18
Citations - 722
Jeanine Kamphuis is an academic researcher from Mental Health Services. The author has contributed to research in topics: Medicine & Insomnia. The author has an hindex of 8, co-authored 10 publications receiving 511 citations.
Papers
More filters
Journal ArticleDOI
Poor sleep as a potential causal factor in aggression and violence.
TL;DR: An overview of existing literature on the relation between poor sleep and aggression, irritability, and hostility is given and individual variation within these neurobiological systems may be responsible for amplified aggressive responses induced by sleep loss in certain individuals.
Journal ArticleDOI
No disease in the brain of a 115-year-old woman
Wilfred F. A. den Dunnen,Wiebo Brouwer,Eveline Bijlard,Jeanine Kamphuis,Klaas van Linschoten,Ellie Eggens-Meijer,Gert Holstege +6 more
TL;DR: The observations indicate that the limits of human cognitive function extends far beyond the range that is currently enjoyed by most individuals and that brain disease, even in supercentanarians, is not inevitable.
Journal ArticleDOI
The relation between poor sleep, impulsivity and aggression in forensic psychiatric patients
TL;DR: The hypothesis that poor sleep is related to impulsive, aggressive behavior in forensic psychiatric patients and the protective effect of treatment of sleep difficulties on aggressive reactivity in (forensic) psychiatric populations is supported.
Journal ArticleDOI
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
Guy M. Goodwin,Scott Aaronson,Oscar Duarte Alvarez,Peter C Arden,Annie Baker,J. Claude Bennett,Catherine Bird,Renske E. Blom,C. Brennan,Donna Brusch,L. Burke,Kete Campbell-Coker,Robin L. Carhart-Harris,Joseph Cattell,Aster Daniel,Charles DeBattista,Boadie W. Dunlop,Katherine Eisen,David Feifel,MacKenzie Forbes,Hannah M Haumann,David J. Hellerstein,Astrid I Hoppe,Muhammad Ishrat Husain,Luke A Jelen,Jeanine Kamphuis,Julie Kawasaki,John R. Kelly,Richard E Key,Ronit Kishon,Stephanie Knatz Peck,Gemma Knight,Martijn H B Koolen,Melanie Lean,Rasmus Wentzer Licht,Jessica L. Maples-Keller,Jan Mars,Lindsey Marwood,Martin McElhiney,Tammy L Miller,Arvin L. Mirow,Sunil Mistry,Tanja Mletzko-Crowe,Liam N Modlin,René Ernst Nielsen,Elizabeth M. Nielson,S.R. Offerhaus,Veronica O'Keane,Tomáš Páleníček,David Printz,Marleen C. Rademaker,Aumer van Reemst,Frederick Reinholdt,Dimitris Repantis,James Rucker,Samuel Rudow,Simon Ruffell,A. John Rush,Robert A. Schoevers,Mathieu Seynaeve,Samantha Shao,Jair C. Soares,Metten Somers,S. C. Stansfield,Diane Sterling,Aaron Strockis,Joyce Tsai,Lucy Visser,Mourad Magdi Wahba,Samuel L. Williams,Allan H. Young,Paula Ywema,Sidney Zisook,E. Malievskaia +73 more
TL;DR: In this paper , a phase 2 trial involving participants with treatment-resistant depression, psilocybin at a single dose of 25 mg, but not 10 mg, reduced depression scores significantly more than a 1-mg dose over a period of 3 weeks but was associated with adverse effects.
Journal ArticleDOI
Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial.
TL;DR: The use of low doses of mirtazapine and quetiapine for the treatment of insomnia support the use of these drugs on the long-term effects regarding effectiveness and adverse effects.